| (Values in U.S. Thousands) | Jun, 2021 | Jun, 2020 | Jun, 2019 | Jun, 2018 | Jun, 2017 |
| Sales | 0 | 20 | 50 | 50 | 0 |
| Sales Growth | -100.00% | -60.00% | unch | unch | -100.00% |
| Net Income | -49,870 | -29,150 | -35,310 | -26,130 | -27,810 |
| Net Income Growth | -71.08% | +17.45% | -35.13% | +6.04% | -19.61% |
Pluristem Therapeutc (PSTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
PLURISTEM THERAPEUTICS INC. is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The Company is developing a pipeline of products, stored ready-to-use, that are derived from the human placenta, a non-controversial source, and not from embryonic stem cells.